ECG Predictors of Atrial Fibrillation Recurrence After Vein Isolation

Atrial fibrillation continues to place a heavy burden on Australian cardiology services. The number of catheter ablations performed each year across hospitals in Sydney, Melbourne, Brisbane, Perth and Adelaide has climbed steadily, yet a meaningful slice of patients still experience atrial fibrillation returning after pulmonary vein isolation. Recurrence rates in contemporary series hover between 20 and 40 percent within the first two years, and identifying who is most likely to relapse has become a priority for electrophysiology teams, hospital administrators and patients themselves.

The 12-lead electrocardiogram remains the cheapest, fastest and most reproducible tool clinicians have for stratifying that risk. Long before a patient reaches the lab, baseline rhythm strips carry information about atrial substrate, ventricular conduction and autonomic tone. After the procedure, the same ECG, often captured on a Holter monitor or an implantable loop recorder, can flag early signals of reconnection. Researchers have spent the past two decades mining these signals, and the resulting literature offers a practical framework for tailoring follow-up.

This article walks through the strongest electrocardiographic predictors of recurrent atrial fibrillation following pulmonary vein isolation. It covers atrial indices such as P-wave duration and dispersion, ventricular markers including fragmented QRS complexes and QRS prolongation, repolarization features like the Tp-e interval, and autonomic surrogates derived from heart rate variability. Each section explains what the marker measures, how it is calculated, and what its presence or absence means for procedural planning.

For clinicians working within the constraints of Medicare-funded care and busy public hospital lists, the goal is practical. A single pre-procedural ECG, interpreted with the right indices in mind, can shift a borderline case from watchful waiting to a more aggressive ablation strategy, or steer a high-risk patient toward closer surveillance after discharge.

P-wave indices and atrial substrate

The P-wave reflects atrial depolarization, and abnormalities within it often betray the structural and electrical remodeling that sustains atrial fibrillation. Maximum P-wave duration greater than 120 milliseconds, P-wave dispersion above 40 milliseconds, and an enlarged P-wave terminal force in lead V1 have each been linked with elevated recurrence risk after pulmonary vein isolation. These are simple measurements taken from a standard 12-lead tracing, and they can be incorporated into a pre-admission clinic assessment without adding cost or complexity.

Signal-averaged P-wave analysis extends this idea by filtering out noise and quantifying the late, low-amplitude potentials that reflect slow conduction across scarred atrial tissue. Prolonged filtered P-wave duration, particularly above 150 milliseconds, has been associated with non-pulmonary-vein triggers and with atrial fibrillation that returns early after ablation. Electrophysiology teams at hospitals such as Royal Prince Alfred in Sydney routinely order signal-averaged studies when the index arrhythmia is persistent or longstanding.

Advanced interatrial block, recognised by a P-wave exceeding 120 milliseconds with a biphasic morphology in the inferior leads, adds further prognostic weight. Patients with this pattern tend to have larger left atrial volumes and more extensive low-voltage regions on voltage mapping, both of which undermine the durability of pulmonary vein isolation. In practice, finding advanced interatrial block on a pre-procedural ECG should prompt a careful review of imaging and may tip the balance toward a more extensive ablation strategy.

Fragmented QRS and ventricular conduction patterns

Although pulmonary vein isolation targets the atria, ventricular conduction offers a window into the broader electrical environment. Fragmented QRS complexes, defined as additional R waves or notching in two or more contiguous leads, have been tied to higher rates of atrial fibrillation recurrence in multiple cohorts. The mechanism likely involves shared fibrosis, since patients with coronary disease, hypertensive heart disease and infiltrative cardiomyopathies often show fragmentation alongside atrial scarring.

QRS duration itself, even within the normal range, carries prognostic information. Prolongation above 100 milliseconds in lead II or V1 at baseline has been linked with structural heart disease and with reduced success rates after ablation. Bundle branch blocks, particularly left bundle branch block, signal conduction system disease that frequently coexists with atrial fibrosis. In Australian registries, the prevalence of pre-existing conduction disease in patients referred for pulmonary vein isolation is around 12 percent, and these patients warrant additional mapping of the cavotricuspid isthmus and coronary sinus region during the index procedure.

The interplay between ventricular and atrial conduction also matters when assessing patients with accessory pathways or inherited arrhythmia syndromes. While most WPW patients follow a different procedural pathway, the same principles of careful atrial substrate assessment inform surveillance after pulmonary vein isolation. In Wolff-Parkinson-White syndrome, the role of accessory pathway location shapes long-term rhythm decisions, and pre-excitation coexisting with atrial fibrillation warrants its own follow-up considerations.

Repolarization markers and the Tp-e interval

Repolarization heterogeneity has emerged as a powerful predictor of arrhythmogenesis in both ventricles and atria. The Tp-e interval, measured from the peak to the end of the T-wave, reflects transmural dispersion of repolarization, and the Tp-e/QT ratio corrects it for overall cycle length. Elevated values, typically above 0.28 in sinus rhythm, have been associated with atrial fibrillation recurrence independent of left atrial size and AF type. The mechanism involves the same ion channel gradients that govern ventricular arrhythmias, suggesting a pan-cardiac susceptibility.

QT dispersion, the difference between maximum and minimum QT intervals across the 12 leads, provides a complementary perspective. Greater dispersion implies non-uniform recovery, which can sustain re-entry in either chamber. After pulmonary vein isolation, persistent QT dispersion on serial ECGs taken during follow-up visits has been linked with later recurrence, particularly in patients with persistent AF at baseline. Routine documentation of QT dispersion in clinic letters is straightforward and requires no specialised equipment.

T-wave alternans, the beat-to-beat variation in T-wave amplitude visible on ambulatory monitoring, completes the picture. Although more commonly used in ventricular risk stratification, microvolt T-wave alternans at rest has correlated with atrial fibrillation recurrence in some small studies. The patterns seen in inherited J-wave syndromes share repolarization features that can occasionally be confused with benign variants, making careful ECG interpretation essential before counselling patients with atypical findings who are considering ablation.

Autonomic indices from heart rate variability

The autonomic nervous system modulates atrial fibrillation triggers, and the ECG, especially ambulatory recordings, can quantify that influence. Heart rate variability indices derived from 24-hour Holter monitoring, including SDNN, rMSSD and the LF/HF ratio, reflect sympathetic and parasympathetic balance. Reduced SDNN and elevated LF/HF ratios in the weeks before pulmonary vein isolation have been associated with higher recurrence rates, suggesting that persistent sympathetic dominance undermines procedural durability.

Deceleration capacity, a measure of vagal tone calculated from RR intervals, has also attracted attention. Patients with impaired deceleration capacity before ablation tend to have larger left atrial volumes and more atrial premature complexes on post-procedural Holters. Australian summer heat, which is well known to provoke atrial fibrillation in vulnerable patients, may interact with autonomic indices to drive symptom flares; this is a useful reminder for clinicians adjusting antiarrhythmic therapy during the warmer months in cities like Brisbane and Perth.

Post-procedural autonomic remodeling, captured by serial Holter recordings at one, three and six months, offers an additional predictive layer. Patients whose HRV indices fail to normalise within the first three months after pulmonary vein isolation face a meaningfully higher risk of arrhythmia returning within the first year. Embedding routine Holter follow-up into the standard EP clinic visit, rather than reserving it for symptomatic patients, makes this information actionable.

Integrating ECG metrics into pre-procedural planning

Combining the markers described above into a coherent pre-procedural assessment is the natural next step. Risk scores that incorporate P-wave duration, fragmented QRS, Tp-e/QT ratio and HRV indices have outperformed traditional clinical variables in several validation cohorts. Adding these ECG metrics to the CHA2DS2-VASc framework, with attention to vascular disease, improves discrimination for both thromboembolic and recurrence risk. Australian centres participating in the national AF registry have begun collecting these indices routinely, and early data suggest they refine patient selection for first-time versus repeat ablation.

The practical workflow involves three ECGs: a baseline 12-lead tracing before the procedure, a pre-discharge ECG to confirm sinus rhythm and rule out early complications, and a Holter monitor at three months. Each captures distinct information. Baseline tracing screens for substrate; pre-discharge tracing confirms acute procedural success; Holter identifies silent atrial premature complexes and assesses autonomic recovery. Patients with multiple abnormal markers on the baseline ECG, for example P-wave duration above 130 milliseconds, fragmented QRS in two territories, and Tp-e/QT ratio above 0.30, should be counselled about higher recurrence risk and considered for closer surveillance.

For trainees building their interpretive skills, the message is that every ECG in an atrial fibrillation patient carries prognostic value well beyond confirming rhythm. Reading P-wave morphology, QRS fragmentation, T-wave dispersion and heart rate variability should become as automatic as measuring the QT interval. The Australian EP community, supported by CSANZ training guidelines and shared protocols across the major teaching hospitals, is well placed to embed these metrics into routine practice.

Each new publication refines the predictive models and brings the field closer to a personalised ablation strategy, and clinicians wanting to follow the evolving evidence can explore the latest arrhythmia articles covering P-wave indices, repolarization markers and autonomic predictors of arrhythmia recurrence.